Revenue segments as reported by the company.

Cannabis Products

Beverage Alcohol Revenue

Distribution Revenue

Insurance Recovery

Other Revenue

Excise Taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

General & Administrative

Share-based compensation

Selling

Marketing & Promotion

Amortization

Research & Development

Impairment

Transaction Costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Aphria

Aphria is the standard for safe, clean, and pure pharmaceutical-grade cannabis at scale, grown in the most natural conditions possible. Aphria vision is to be the best performing cannabis company globally, providing investors with access to the most accretive cannabis opportunities around the world.

Demand for weed has "noticeably increased" as the coronavirus pandemic forces people indoors, an analyst said.

Here's Why This Pot Stock May Stand Out As Coronavirus Stokes Demand

Along with just about every other cannabis stock, Aphria has been in a tailspin. And the implosion of the overall market has made things even worse.

Aphria Stock Is a Solid Pick for Speculators Amid Market Turmoil

GW Pharmaceuticals

There are some good deals out there right now.

2 Dirt-Cheap Cannabis Stocks to Buy Right Now

Marijuana stocks have been some of the hardest hit in this market downturn, and there may be more trouble ahead for the likes of Aphria Inc.

Will a Rich War Chest Help Aphria Stock?

HEXO Corp

North American pot stocks are in trouble, but cannabis companies in other parts of the world still have good prospects.

The Cannabis Industry's Struggles Could Be Great News for These Companies

What does the future look like for Aphria stock? It depends on its success in growing market share and international sales.

Aphria Needs Strong Sales Growth to Rise High Again

Here's one pot stock that's well-positioned to handle an economic downturn.

This Could Be the Biggest Cannabis Winner of the Stock Market Crash

Sell-side analysts at Stifel initiated coverage of Aphria Inc. APHA, +0.56% APHA, +2.33% with a hold rating and Hexo Corp.

Stifel initiates cannabis producer Aphria coverage with a hold rating, Hexo with a sell

AbbVie

Agenus

Atreca

Bicycle Therapeutics Plc - ADR

Bristol-Myers

Catalyst Pharmaceuticals

Crinetics Pharmaceuticals Inc

Amicus Therapeutics

OrganiGram Holdings Inc.

Pfizer

Arcus Biosciences

Sarepta Therapeutics

The coronavirus induced sell-off has created a number of attractive buying opportunities.

These 14 Stocks Are Stupid Cheap

Aurora Cannabis

Cronos Group

Concerns over the global supply chain weighed on these top pot stocks last month.

Why Aphria, Aurora Cannabis, and Cronos Group Sank in February

Cannabis stocks are not known for their stability. However, the ridiculous drop in Aphria stock suggests that this is a truly undervalued opportunity.

This Plunge in Aphria Stock Doesn’t Make Sense

The bear raid has pushed Aphria stock down to the point where the risk-reward favors a long position. Here's everything you need to know now.

Short Sellers Are Taking a Big Risk With Aphria Stock

Village Farms International

If you're looking for good deals in the cannabis market, these two companies are even more undervalued than usual with the market falling on coronavirus concerns.

2 High-Growth Cannabis Stocks at Rock-Bottom Prices

In the second quarter, its sales from adult-use cannabis grew 45% over the second quarter to 29.0 million CAD from 20.0 million CAD in the first quarter. Meanwhile, Aphria’s medical business had sales that were basically flat at 10.1 million CAD, down from 10.2 million CAD in the first quarter.

As Demand Skyrockets in Germany, Aphria Stock Looks More Valuable

It follows in the footsteps of four other African countries that have loosened restrictions on cannabis.

Malawi Legalizes Medical Marijuana

Canadian pot grower Aphria Inc. (NYSE: APHA) did one thing right last year.

Why Aphria Stock Might Be Worth Another Look

In the latest trading session, Aphria Inc. (APHA) closed at $3.82, marking a -0.26% move from the previous day.

Aphria Inc. (APHA) Stock Moves -0.26%: What You Should Know

Aphria, Cronos Group, and OrganiGram Holdings are all screaming bargains relative to their long-term outlook.

Why I Bought These 3 Ridiculously Cheap Pot Stocks

Constellation Brands

Investors looking to profit from the cannabis industry's growth can pick a pure-play company, or one for which marijuana-related gains would be the icing on an already-large cake.

Better Buy: Aphria vs. Constellation Brands

Aphria stock was the darling of the cannabis sector in 2019 for the underlying company delivering profits. Now, that success is turning into a sentiment headwind.

Is Aphria Stock a Victim of Its Own Success?

Canopy Growth

These stocks hold the promise of long-term benefits despite the current market downturn for cannabis.

5 Best Cannabis Stocks to Own for the Next Decade

Like other cannabis investments, Aphria stock could make a recovery run in 2020. However, doing so may require patience that Wall Street is so far unwilling to give.

News for Aphria Stock (APHA)